Detalles de la búsqueda
1.
Identifying potential immuno-oncology targets in salivary gland mucoepidermoid carcinoma based on inflammatory status and treatment response.
J Oral Pathol Med;
52(10): 939-950, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37756121
2.
Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity.
Hepatology;
70(5): 1614-1630, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077409
3.
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors.
PeerJ;
11: e15350, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37334114
4.
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma.
Front Oncol;
12: 877194, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35664774
5.
Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.
Front Oncol;
12: 1021632, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36531039
6.
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.
Front Oncol;
12: 1124912, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36686801
7.
Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
Asian Pac J Cancer Prev;
17(6): 2935-40, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27356714
Resultados
1 -
7
de 7
1
Próxima >
>>